Comparison
46 Xy Partial Gonadal Dysgenesis C4510744 vs 4 Hydroxyphenylacetic Aciduria C1848680
Clinical comparison between 46 XY Partial Gonadal Dysgenesis and 4 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
46 Xy Partial Gonadal Dysgenesis C4510744
A genetic condition where XY individuals have underdeveloped gonads causing atypical genital development and possible hormone deficiencies. Care is individualized, often involving hormone therapy and surgical options.
4 Hydroxyphenylacetic Aciduria C1848680
A metabolic disorder where the body cannot properly break down certain amino acids. Typically detected in infancy through screening. Treated with dietary modifications and monitoring.
6 comparison axes
Onset
46 Xy Partial Gonadal Dysgenesis C4510744
0-0
4 Hydroxyphenylacetic Aciduria C1848680
Variable
Onset patterns differ
Severity
46 Xy Partial Gonadal Dysgenesis C4510744
severe
4 Hydroxyphenylacetic Aciduria C1848680
moderate
Different severity levels
Chronic
46 Xy Partial Gonadal Dysgenesis C4510744
Chronic
4 Hydroxyphenylacetic Aciduria C1848680
Chronic
Differing course
Communicable
46 Xy Partial Gonadal Dysgenesis C4510744
No
4 Hydroxyphenylacetic Aciduria C1848680
No
Different transmission
Body System
46 Xy Partial Gonadal Dysgenesis C4510744
reproductive
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Same/different system
Category
46 Xy Partial Gonadal Dysgenesis C4510744
genetic
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Different category
Bottom line
46-xy-partial-gonadal-dysgenesis-C4510744 and 4-hydroxyphenylacetic-aciduria-C1848680 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Partial Gonadal Dysgenesis C4510744 | 4 Hydroxyphenylacetic Aciduria C1848680 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may be present from birth. | No characteristic genital abnormality is established. | High |
| Metabolic features | Possible hormone deficiency; amino-acid metabolism is not the core feature. | May involve nonspecific findings or only an abnormal urine metabolite. | Moderate |
| Timing | Features are typically congenital. | Detection is variable, often during infancy or metabolic testing. | Moderate |
When to favor each condition
Choose 46 Xy Partial Gonadal Dysgenesis C4510744 when
Atypical genitalia with a 46,XY karyotype
This pattern aligns with gonadal dysgenesis rather than a urine metabolite finding.
High
Underdeveloped gonads or suspected sex-hormone deficiency
These features match the supplied reproductive description.
Moderate
Specialist disorder-of-sex-development evaluation
Care may include individualized hormone or surgical counseling.
Moderate
Choose 4 Hydroxyphenylacetic Aciduria C1848680 when
Elevated urinary 4-hydroxyphenylacetic acid
This identifies the laboratory abnormality but still needs interpretation.
High
Metabolic evaluation without genital atypicality
A metabolic finding is more consistent than gonadal dysgenesis.
Moderate
Need to separate a result from a diagnosis
Aciduria alone does not establish one specific disease.
High
How key tests differ
| Test | 46 Xy Partial Gonadal Dysgenesis C4510744 | 4 Hydroxyphenylacetic Aciduria C1848680 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY by definition | No characteristic karyotype | Supports the left concept but does not measure gonadal function. |
| Hormone tests and gonadal imaging | May suggest impaired gonadal function or underdevelopment | Not expected to define the finding | Results require specialist correlation; no cutoff is supplied. |
| Urine organic acid analysis | No specific pattern established | Elevated 4-hydroxyphenylacetic acid | An abnormal result, not a complete diagnosis. |
Prognosis comparison
46 Xy Partial Gonadal Dysgenesis C4510744
- Outcome
- Chronic, variable outcome with individualized care.
- Factors
- Gonadal development, hormones, associated findings, and treatment decisions.
4 Hydroxyphenylacetic Aciduria C1848680
- Outcome
- Outcome is not established from the metabolite alone; supplied severity is moderate.
- Factors
- Underlying cause, detection timing, and response to monitoring or diet.
Time frame: Long-term follow-up; congenital on the left and variable on the right.
Severity differs, but precise prognosis cannot be inferred from these data.
Complications comparison
| Complication | Presentation |
|---|---|
| Hormone deficiency or infertility | Possible because the gonads are underdeveloped. Not established from the supplied data. Endocrine and fertility effects need individualized assessment. |
| Metabolic monitoring | Not the primary management described. Diet modification and monitoring may be considered. Exact diet, thresholds, and doses are not established here. |
| Diagnostic uncertainty | Phenotype and management vary. The metabolite may have more than one cause. Neither concept should be assigned from one feature alone. |
Patient education highlights
- HighDifferent conditions
These involve different systems and are not alternative labels for one diagnosis.
- HighSpecialist interpretation
Genetics, endocrine, surgical, or metabolic specialists should interpret findings.
- MediumNo self-treatment
Do not begin hormones, surgery, or dietary restriction without clinical guidance.